Skip to content

Clinical trials

Recruiting Lung Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Recruiting Country / region: Italy Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20172
20192
20202
20211
20224
202310
202410
202522
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting64

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Institute of Oncology4
Merck Sharp & Dohme LLC4
Pfizer4
Scientific Institute San Raffaele4
Bristol-Myers Squibb3
IRCCS Azienda Ospedaliero-Universitaria di Bologna3
Revolution Medicines, Inc.3
BioNTech SE2
Eli Lilly and Company2
Fondazione IRCCS Policlinico San Matteo di Pavia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms64
Carcinoma, Non-Small-Cell Lung33
Neoplasms9
Breast Neoplasms8
Lung Diseases7
Carcinoma6
Head and Neck Neoplasms6
Small Cell Lung Carcinoma6
Bronchial Neoplasms5
Colorectal Neoplasms5

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.